Softwr

Research · head to head

DNAnexus vs Reduct

DNAnexus logo

DNAnexus

Research

Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage

From
On request
Rated
-
Full reviewWebsite
Reduct logo

Reduct

Research

Edit video by editing its transcript, built for researchers rather than video editors

From
$12/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: DNAnexus no pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.; Reduct automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • They diverge on capability: DNAnexus covers Governed data storage, Reduct covers Transcript-based editing.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which DNAnexus and Reduct actually diverge.

Attributes where DNAnexus and Reduct differ
AttributeDNAnexusReduct
Starting priceOn request$12/month
Pricing modelquotePer user per month
PlatformsWeb, LinuxWeb, API

Identical on both: free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in DNAnexus

  • Governed data storage
  • Workflow execution
  • App building
  • Controlled collaboration
  • Compliance posture
  • Cohort browsing

Only in Reduct

  • Transcript-based editing
  • Automatic transcription
  • Human transcription add-on
  • Highlight and tagging
  • Reel assembly
  • Redaction
  • Multicam sync
  • Collaborative commenting

What people use each for

The jobs each tool is most often brought in to do.

DNAnexus

  • A clinical diagnostics laboratory that needs a CLIA and CAP aligned environment for production sequencing pipelines without building the compliance evidence itselfnot Reduct
  • A pharma sponsor analysing genomic endpoints in a registrational programme where 21 CFR Part 11 records are requirednot Reduct
  • A biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distributenot Reduct
  • A diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source codenot Reduct

Reduct

  • A research team that runs twenty customer interviews a quarter and needs stakeholders across product and design to watch and comment without buying them seatsnot DNAnexus
  • A researcher assembling a five-minute highlight reel of user pain points for an executive review, working from transcript text rather than a video timelinenot DNAnexus
  • A public defender office redacting faces and identifying details from body-camera and interview footage before disclosurenot DNAnexus
  • A global insights team transcribing and translating interviews across several languages before coding them thematicallynot DNAnexus

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

DNAnexus

  • No pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.
  • Compute and storage are billed through the platform rather than at underlying cloud list price, so the compliance envelope carries a persistent margin on every terabyte and core hour, which grows with the science rather than staying fixed.
  • Data egress at genomic scale is slow and chargeable, so leaving the platform later is a real project rather than a contract decision, and that gravity weakens negotiating position at renewal.
  • The regulated and validated configurations sit in a higher commercial tier than the research configuration, so an organisation that starts in research mode and later needs GxP faces a repricing rather than a setting change.
  • Bioinformaticians used to running Nextflow on their own infrastructure find the platform abstractions constraining, and porting an existing pipeline into the app model is engineering work that does not carry over to any other platform.

Reduct

  • Automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • Transcription hours are a pooled annual allowance rather than monthly, so a team that front-loads a large research programme in one quarter can exhaust the year and face overage charges for the remaining nine months.
  • The Personal tier caps file size at 4GB, which is easily exceeded by an hour of multicam or high-bitrate recording, forcing an upgrade for reasons unrelated to the feature set.
  • Independent review coverage is very thin, so there is little public evidence to check vendor claims against, and buyers effectively have to rely on their own trial rather than peer signal.
  • The company has raised only about 4 million USD since 2018 and remains small, which makes enterprise vendor viability review and data-export planning genuinely necessary before you make it the home of years of research recordings.

Pricing, plan by plan

DNAnexus

On request
  • DNAnexus Platform$undefined/year
    • Quoted per organisation through a sales process
    • Storage and compute billed through the platform rather than at cloud list price
    • Regulated and validated configurations are a separate commercial tier

Reduct

$12/month
  • Personal$12/month
    • 120 transcription hours per editor per year
    • Up to 10 commenters
    • 720p export
  • Professional$40/month
    • 300 transcription hours per editor per year
    • Up to 50 commenters
    • Timeline view
  • Enterprise$75/month
    • 4K export
    • SAML and Google SSO
    • SOC 2 Type II

Which should you pick?

Choose DNAnexus if

  • You need governed data storage.
  • You work on Web, Linux.
  • You also want workflow execution.
DNAnexus review

Choose Reduct if

  • You need transcript-based editing.
  • You work on Web, API.
  • You also want automatic transcription.
Reduct review

Questions people ask

Is DNAnexus or Reduct better?
Neither clearly leads. DNAnexus starts at On request and Reduct at $12/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, DNAnexus or Reduct?
DNAnexus starts at On request and Reduct at $12/month.
Does DNAnexus or Reduct run on more platforms?
DNAnexus runs on Web, Linux. Reduct runs on Web, API.
What is DNAnexus best used for?
DNAnexus is most often used for a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself, a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required, a biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distribute, a diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source code. Of those, a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself and a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required are not what Reduct is typically brought in for.
What can DNAnexus do that Reduct cannot?
DNAnexus covers Governed data storage, Workflow execution, App building, Controlled collaboration. Reduct covers Transcript-based editing, Automatic transcription, Human transcription add-on, Highlight and tagging.

Answered from the vendors’ own pages

DNAnexus: Why pay for DNAnexus instead of raw AWS?

For the compliance evidence. GxP, FedRAMP, CLIA, CAP and Part 11 coverage removes a validation programme most organisations would otherwise have to build and maintain themselves.

Reduct: How is Reduct priced?

Per editor per month: 12 USD on Personal, 40 on Professional and from 75 on Enterprise, with transcription supplied as a pooled annual hour allowance per editor.

DNAnexus: Is validated use included?

No. Regulated and validated configurations sit in a separate commercial tier from ordinary research use.

Reduct: Do stakeholders who only watch and comment need a paid seat?

No. Commenters are separate from editor seats and included up to 10 on Personal and 50 on Professional, which is the main reason research teams choose it.

DNAnexus: Can I get my data out?

Yes, but egress at genomic scale is chargeable and slow, so plan exit costs at the point of signing.

Reduct: Can I use it as a proper video editor?

Only up to a point. It handles transcript-driven cutting, reels and multicam sync, then exports to Premiere Pro or Final Cut Pro when you need real finishing.

DNAnexus: Does it host UK Biobank?

Yes, DNAnexus hosts the UK Biobank research analysis platform, which has its own access approval and cost terms.

Reduct: Is there a free tier?

No. There is a 14-day trial on Professional with five hours of transcription, but no permanent free plan.

Share

Related pages

More on DNAnexus

More on Reduct

Keep looking

Other head to heads